1,514
Views
12
CrossRef citations to date
0
Altmetric
Short Communication

Corneal antinociceptive effect of (-)-α-bisabolol

, & ORCID Icon
Pages 1089-1092 | Received 17 Jun 2016, Accepted 18 Jan 2017, Published online: 14 Feb 2017

References

  • Abdul Nasir NA, Alyautdin RN, Agarwa R, Nukolova N, Cheknonin V, Mohd Ismail N. 2013. Ocular tissue distribution of topically applied PEGylated and non-PEGylated liposomes. Adv Mater Res. 832:1–8.
  • Abdul Nasir NA, Agarwal P, Agarwal R, Iezhitsa I, Alyautdin R, Nukolova NN, Chekhonin VP, Mohd Ismail N. 2015. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes. Drugs Deliv. 14:1–7.
  • Barreto RS, et al. 2016. Evidence for the involvement of TNF-α and IL-1β in the antinociceptive and anti-inflammatory activity of Stachys lavandulifolia Vahl. (Lamiaceae) essential oil and (-)-α-bisabolol, its main compound, in mice. J Ethnopharmacol. 191:9–18.
  • Bates BD, Mitchell K, Keller JM, Chan CC, Swaim WD, Yaskovich R, Mannes AJ, Iadarola MJ. 2010. Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist. Pain. 149:522–528.
  • Bhatia SP, McGinty D, Letizia CS, Api AM. 2008. Fragrance material review on alpha-bisabolol. Food Chem Toxicol. 46 (Suppl 11):S72–S76.
  • Belmonte C, Acosta MC, Gallar J. 2004. Neural basis of sensation in intact and injured corneas. Exp Eye Res. 78:513–525.
  • Bucolo C, Drago F, Salomone S. 2012. Ocular drug delivery: a clue from nanotechnology. Front Pharmacol. 3:1–3.
  • Calder L, Balasubramanian S, Stiell I. 2005. Topical nonsteroidal anti-inflammatory drugs for corneal abrasions: meta-analysis of randomized trials. Acad Emerg Med. 12:467–473.
  • Cunha Junior AS, Fialho SL, Carneiro LB, Oréfice F. 2003. Microemulsions as drug carrier for topical ocular administration. Arq Bras Oftalmol. 66:385–391.
  • Das S, Suresh PK. 2010. Drug delivery to eye: special reference to nanoparticles. Int J Drug Deliv. 2:12–21.
  • Farazifard R, Safarpour F, Sheibani V, Javan M. 2005. Eye-wiping test: a sensitive animal model for acute trigeminal pain studies. Brain Res Brain Res Protoc. 16:44–49.
  • Furrer P, Mayer JM, Plazonnet B, Gurny R. 2002. Ocular tolerance of absorption enhancers in ophthalmic preparations. AAPS Pharm Sci. 4:6–10.
  • Gaynes BI, Fiscella R. 2002. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review. Drug Saf. 25:233–250.
  • Kamatou GPP, Viljoen AM. 2010. A review of the application and pharmacological properties of α-bisabolol and α-bisabolol-rich oils. J Am Oil Chem Soc. 87:1–7.
  • Kim SJ, Flach AJ, Jampol LM. 2010. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 55:108–133.
  • Lee J, Jun H, Jung E, Ha J, Park D. 2010. Whitening effect of alpha-bisabolol in Asian women subjects. Int J Cosmet Sci. 32:299–303.
  • Leite GO, Leite LH, Sampaio Rde S, Araruna MK, de Menezes IR, da Costa JG, Campos AR. 2011. (-)-α-Bisabolol attenuates visceral nociception and inflammation in mice. Fitoterapia. 82:208–211.
  • Leite LHI, Leite GO, Silva Coutinho T, de Sousa SD, Sampaio RS, da Costa JG, de Menezes IR, Campos AR. 2014. Topical antinociceptive effect of Vanillosmopsis arborea Baker on acute corneal pain in mice. Evid Based Complement Alternat Med. Article ID 708636.
  • Leite GO, Dubois AF, Seeger RL, Boligon AA, Costa JGM, Lugokenski TH, Campos AR, Fachinetto R, Kamdem JP, Rocha JBT, et al. 2016. In vitro antioxidant activityo of Vanillomopsis arborea Baker aqueous extracts, essential oil and isolated compound: (-)-α-bisabolol. Pharmacologia. 7:193–201.
  • Melo LT, Panchaligam V, Aviv-Arber L, Cherkas P, Campos AR, Sessle BJ. 2015. Effects of the natural substance (-)-alpha-bisabolol on trigeminal central sensitisation and sensorimotor behaviour induced by acute noxious orofacial stimuli. Neuroscience meeting planner. Washington (DC): Society for Neuroscience. Online.
  • Moreira LB, Kasetsuwan N, Sanchez D, Shah SS, LaBree L, McDonnell PJ. 1999. Toxicity of topical anesthetic agents to human keratocytes in vivo. J Cataract Refract Surg. 25:975–980.
  • Morselli LNS. 2014. Estudos de pré-formulação e desenvolvimento de cosméticos Dimora Del Sole. Araraquara, Brasil: Universidade Estadual Paulista.
  • Narayanan V. 2008. Synthesis of mesoporous silica microsphere from dual surfactant. Mater Res. 11:443–446.
  • Oliveira JR, Fabrin TMC, Galbiati TA, Barboza LN, Furlanetto DO, Ferreira MF, de Oliveria JC, da Silva GR, Gasques LS. 2014. Interference check the solvent propylene glycol on the effect of propolis on crawler production Bombyx mori L. (Lepidoptera: Bombicidae) compared to the alcoholic extract of própolis. Arq Ciênc Vet Zool. 17:43–48.
  • Ortiz MI, Fernández-Martínez E, Soria-Jasso LE, Lucas-Gómez I, Villagómez-Ibarra R, González-García MP, Castañeda-Hernández G, Salinas-Caballero M. 2016. Isolation, identification and molecular docking as cyclooxygenase (COX) inhibitors of the main constituents of Matricaria chamomilla L. extract and its synergistic interaction with diclofenac on nociception and gastric damage in rats. Biomed Pharmacother. 78:248–256.
  • Pastore Jr, Araújo VF. 2006. Plantas da Amazônia para produção cosmética. Brasília, Brasil: Universidade de Brasilia.
  • Reus M, Carmigna F, Senna E, Campos AM. 2009. Polymeric nanoparticles in topical ocular administration of drugs. Lat Am J Pharm. 28:125–132.
  • Rocha NF, Rios ER, Carvalho AM, Cerqueira GS, Lopes Ade A, Leal LK, Dias ML, de Sousa DP, de Sousa FC. 2011. Anti-nociceptive and anti-inflammatory activities of (-)-α-bisabolol in rodents. Naunyn Schmiedebergs Arch Pharmacol. 384:525–533.
  • Schweiger D, Schoelermann AM, Filbry A, Hamann T, Moser C, Rippke F. 2015. Highly efficient and compatible shampoo for use after hair transplant. Clin Cosmet Investig Dermatol. 8:355–360.
  • Shaaban HA, Edris HA. 2015. Factors affecting the phase behavior and antimicrobial activity of carvacrol microemulsions. J Oleo Sci. 64:393–404.
  • Smith HS, Goldman RD. 2012. Topical nonsteroidal anti-inflammatory drugs for corneal abrasions in children. Can Fam Physician. 58:748–749.
  • Solovăstru LG, Stîncanu A, De Ascentii A, Capparé G, Mattana P, Vâţă D. 2015. Randomized, controlled study of innovative spray formulation containing ozonated oil and α-bisabolol in the topical treatment of chronic venous leg ulcers. Adv Skin Wound Care. 28:406–409.
  • Souza JG, Dias K, Pereira TA, Bernardi DS, Lopez RF. 2014. Topical delivery of ocular therapeutics: carrier systems and physical methods. J Pharm Pharmacol. 66:507–530.
  • Spiegel M. 2012. Alpha-bisabolol – naturalness vs. sustainability? Sofw J. 138:1–8.